Phase II trial of piritrexim and DTIC using an alternating dose schedule in metastatic melanoma. [electronic resource]
Producer: 19960119Description: 488-90 p. digitalISSN:- 0277-3732
- Administration, Oral
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Dacarbazine -- administration & dosage
- Drug Administration Schedule
- Female
- Humans
- Infusions, Intravenous
- Liver Neoplasms -- drug therapy
- Lung Neoplasms -- drug therapy
- Male
- Melanoma -- drug therapy
- Middle Aged
- Pyrimidines -- administration & dosage
- Remission Induction
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.